We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+25.71%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$287M
AUM Growth
-$101M
(-26%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-45.61%
Top 10 Holdings %
Top 10 Hldgs %
58.33%
Holding
64
New
21
Increased
4
Reduced
11
Closed
12
Top Buys
| 1 |
Labcorp
LH
|
+$13.4M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
+$12M |
| 3 |
Medtronic
MDT
|
+$8.96M |
| 4 |
Tyra Biosciences
TYRA
|
+$8.79M |
| 5 |
Organon & Co
OGN
|
+$8.22M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$85.3M |
| 2 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
+$50.2M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$19.1M |
| 4 |
United Therapeutics
UTHR
|
+$17.6M |
| 5 |
Cigna
CI
|
+$13.3M |
Sector Composition
| 1 | Healthcare | 99.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Labcorp
LH
$22.6B
| $49.4M | 17.19% |
225,902
+60,779
| +37% | +$13.4M |
|
|
2
Cigna
CI
$80.2B
| $27.6M | 9.62% |
76,086
-40,467
| -35% | -$13.3M |
|
3
Globus Medical
GMED
$10.3B
| $21.1M | 7.35% |
393,420
-138,669
| -26% | -$7.46M |
|
|
4
Madrigal Pharmaceuticals
MDGL
$12.4B
| $13.6M | 4.74% |
+51,000
| New | +$12M |
|
5
GSK
GSK
$103B
| $11.3M | 3.93% |
263,445
-307,946
| -54% | -$12.7M |
|
6
Zimmer Biomet
ZBH
$17.6B
| $9.79M | 3.41% |
74,179
+1,879
| +3% | +$235K |
|
|
7
Medtronic
MDT
$102B
| $9.15M | 3.19% |
+105,000
| New | +$8.96M |
|
|
8
Organon & Co
OGN
$3.55B
| $9.01M | 3.14% |
+479,023
| New | +$8.22M |
|
|
9
Tyra Biosciences
TYRA
$1.96B
| $8.79M | 3.06% |
+535,741
| New | +$8.79M |
|
10
Embecta
EMBC
$184M
| $7.77M | 2.71% |
585,418
-150,590
| -20% | -$2.33M |
|
11
Teleflex
TFX
$5.76B
| $7.66M | 2.67% |
33,878
-2,649
| -7% | -$629K |
|
12
Arcutis Biotherapeutics
ARQT
$3.35B
| $6.3M | 2.19% |
635,969
| – | – |
|
13
BridgeBio Pharma
BBIO
$16.5B
| $6.28M | 2.19% |
203,174
+71,421
| +54% | +$2.43M |
|
14
Humacyte
HUMA
$191M
| $6.22M | 2.17% |
+2,000,000
| New | +$6.73M |
|
15
ANI Pharmaceuticals
ANIP
$1.83B
| $6.04M | 2.1% |
+87,354
| New | +$5.27M |
|
|
ATXS
16
DELISTED
Astria Therapeutics
ATXS
| $5.77M | 2.01% |
+410,267
| New | +$5.11M |
|
17
ARS Pharmaceuticals
SPRY
$756M
| $5.48M | 1.91% |
536,163
-569,748
| -52% | -$4.25M |
|
18
Healthcare Services Group
HCSG
$1.65B
| $5.26M | 1.83% |
421,317
-388,990
| -48% | -$4.31M |
|
19
Apogee Therapeutics
APGE
$10.1B
| $5.18M | 1.81% |
+78,000
| New | +$3.41M |
|
|
FUSN
20
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $5.18M | 1.8% |
243,035
-3,001
| -1% | -$35.9K |
|
21
Erasca
ERAS
$6.06B
| $5M | 1.74% |
+2,427,184
| New | +$4.85M |
|
22
X4 Pharmaceuticals
XFOR
$379M
| $4.99M | 1.74% |
119,614
| – | – |
|
23
Nuvation Bio
NUVB
$2.05B
| $4.86M | 1.69% |
+1,336,231
| New | +$2.57M |
|
24
Scholar Rock
SRRK
$6.44B
| $4.86M | 1.69% |
+273,720
| New | +$4.31M |
|
25
Integra LifeSciences
IART
$1.43B
| $4.86M | 1.69% |
+137,000
| New | +$5.48M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA